Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

These new skin treatments are safer and more effective with minimal side effects.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Timely diagnosis and aggressive treatment with high-dose steroids and B-cell depletion therapies are effective for severe acute cutaneous lupus.

Abrocitinib may effectively treat stubborn alopecia universalis.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Ruxolitinib helped a man regrow his beard after years of hair loss.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Tofacitinib is effective and safe for treating severe alopecia areata.

Janus kinase inhibitors may help treat lichen planopilaris.

Combining hydroxychloroquine and pimecrolimus can effectively treat hair loss from discoid lupus.

Leflunomide is more likely to help treat alopecia areata than cause it.

Hydroxychloroquine may help COVID-19 patients with lupus.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Guselkumab significantly improves psoriasis symptoms within 12 weeks.